Deborah Rhodes, MD, FACP
Professor of Internal Medicine (General Medicine)Cards
About
Research
Publications
2025
Molecular Breast Imaging and Digital Breast Tomosynthesis for Dense Breast Screening: The Density MATTERS Trial.
Hruska C, Hunt K, Larson N, Miller P, Ellis R, Shermis R, Rauch G, Conners A, Gasal Spilde J, Semaan D, Siegal E, Zingula S, Mandava S, Martin T, Ahmed R, Whaley D, Adrada B, Gray L, Mehta R, Roll R, Redfern R, O'Connor M, Rhodes D. Molecular Breast Imaging and Digital Breast Tomosynthesis for Dense Breast Screening: The Density MATTERS Trial. Radiology 2025, 316: e243953. PMID: 40985829, DOI: 10.1148/radiol.243953.Peer-Reviewed Original ResearchConceptsMolecular breast imagingAnnual screening roundsDigital breast tomosynthesisDense breastsIncremental cancer detection rateNode-negative cancersTyrer-Cuzick riskCancer detection rateInterval cancer rateBreast tomosynthesisInvasive cancer detectionBreast imagingYear 1Year 2Invasive cancerMulticenter trialBreast screeningBreast densityCancer ratesAdvanced cancerCancerCancer detectionFunctional uptakePrevalenceBreastA randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center
Ghosh K, Jenkins S, Ridgeway J, Austin J, Borah B, Patel B, Rhodes D, Norman A, Ramos E, Jewett M, Gonzalez C, Hernandez V, Singh D, Vachon C, Suman V. A randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center. BMC Women's Health 2025, 25: 274. PMID: 40452038, PMCID: PMC12128533, DOI: 10.1186/s12905-025-03818-9.Peer-Reviewed Original ResearchConceptsMammographic breast densityPerceived lifetime riskLevels of anxietyRisk of BCLatina womenBreast cancerLifetime risk of BCBreast density notificationLifetime risk scoreQualified health centersState-Trait Anxiety Inventory ScaleMethodsA randomized controlled clinical trialPerceived RiskSelf-reported levelsGail modelDensity notificationUsual careEnhance careMammogram resultsInterpersonal careBC riskIntervention groupT2 surveyScreening mammographyHealth centersImpact of an electronically‐integrated clinical pathway on hospital initiation of medications for alcohol use disorder and subsequent hospital utilization
Cole K, Weimer M, Wang K, Fiellin D, Advani A, Shah N, Zemaitis C, Rhodes D. Impact of an electronically‐integrated clinical pathway on hospital initiation of medications for alcohol use disorder and subsequent hospital utilization. Journal Of Hospital Medicine 2025, 20: 1044-1051. PMID: 40221929, DOI: 10.1002/jhm.70049.Peer-Reviewed Original ResearchClinical pathwayAlcohol use disorderED returnUse disorderHospital-based strategiesAcademic medical centerTertiary academic medical centerDays of dischargeHospital InitiativeInitiation of medicationHealth systemHospital utilizationMultiple barriersIncreased oddsConsecutive adult inpatientsHospital dischargeSecondary outcomesIncreased low ratesAdult inpatientsMedical CenterTreatment initiationHospitalVoluntary useReadmissionMedicationEffectiveness of Breast Density Educational Interventions on Mammography Screening Adherence Among Underserved Latinas: A Randomized Controlled Trial
Austin J, Jenkins S, Suman V, Ridgeway J, Patel B, Ghosh K, Rhodes D, Borah B, Norman A, Ramos E, Jewett M, Gonzalez C, Hernandez V, Singh D, Breitkopf C, Vachon C. Effectiveness of Breast Density Educational Interventions on Mammography Screening Adherence Among Underserved Latinas: A Randomized Controlled Trial. Journal Of Women's Health 2025, 34: 491-503. PMID: 39969957, PMCID: PMC12408887, DOI: 10.1089/jwh.2024.0273.Peer-Reviewed Original ResearchFederally Qualified Health CentersRandomized Controlled TrialsAnnual mammogramsBreast densityAdherence ratesIncreased risk of breast cancerRisk of breast cancerMammography screening adherenceQualified health centersElectronic health recordsMammographically dense breastsScreening adherenceUnderserved LatinasMammography screeningHealth recordsBaseline mammogramEducational interventionHealth centersDense breastsInformation interventionLatinasControlled TrialsMammogramsGroup assignmentSurvey responses
2024
A Survey of Patient Experience During Molecular Breast Imaging
Hruska C, Gray L, Jenkins S, Block E, Hunt K, Conners A, Zingula S, O'Connor M, Rhodes D. A Survey of Patient Experience During Molecular Breast Imaging. Journal Of Nuclear Medicine Technology 2024, 52: jnmt.123.266856. PMID: 38839120, PMCID: PMC11149590, DOI: 10.2967/jnmt.123.266856.Peer-Reviewed Original ResearchPatient experiencePersonal history of breast cancerDense breastsSurvey of patient experienceHistory of breast cancerPositive patient experienceAssociated with respondents' ageImprove patient experienceSoliciting patient feedbackPatient comfort levelMammographically dense breastsPatient feedbackStudy consentMolecular breast imagingNeck discomfortRespondents' agePersonal historyMammographyComfort levelSource of discomfortBreast compressionBreast cancerEvaluating patientsInfluence willingnessRespondents
2023
Improving Post-procedure Outcomes With Clinical Care Pathway for Enteral Access
Miller S, Abou-Azar S, Owusu K, Judson B, Rhodes D, Morton J. Improving Post-procedure Outcomes With Clinical Care Pathway for Enteral Access. The American Surgeon 2023, 89: 6362-6365. PMID: 37203186, DOI: 10.1177/00031348231177914.Peer-Reviewed Original ResearchA Novel Approach to Delivering Evidence-based, High-quality Care in Psychiatry Through an Electronic Integrated Care Pathway (eICP) Pilot
Li L, Kruger M, Kim N, Ong S, Riley S, Cameron K, Koslosky K, Rhodes D. A Novel Approach to Delivering Evidence-based, High-quality Care in Psychiatry Through an Electronic Integrated Care Pathway (eICP) Pilot. Psychiatric Quarterly 2023, 94: 103-111. PMID: 36840898, PMCID: PMC9959944, DOI: 10.1007/s11126-023-10016-z.Peer-Reviewed Original ResearchConceptsElectronic health recordsUser-friendly experienceEvidence-based decision support toolUsage trackingDecision support toolSupport toolHealth recordsIntegrated care pathwayNovel approachService areaTeam structureImplementationEarly adoptionAdoptionTechnology columnHealth service areasAcademic medical centerQuality of careHigh-quality careTrackingAdoption resultsCare pathwayFuture directionsMedical CenterTechnologyBreast Cancer Mode of Detection in a Population-Based Cohort
Basappa S, Finney Rutten L, Hruska C, Olson J, Jacobson D, Rhodes D. Breast Cancer Mode of Detection in a Population-Based Cohort. Mayo Clinic Proceedings 2023, 98: 278-289. PMID: 36737116, PMCID: PMC9907001, DOI: 10.1016/j.mayocp.2022.10.010.Peer-Reviewed Original ResearchConceptsPopulation-based cohortBreast cancerAdvanced cancerBreast densityRetrospective medical record reviewDense breastsPositive lymph nodesFirst-time diagnosisRochester Epidemiology ProjectMedical record reviewStage of diseaseLarger tumor sizeWomen age 40High-grade tumorsMultiple logistic regressionYears of ageLymph nodesRecord reviewTumor characteristicsTumor sizeCancer characteristicsCancer modeAge 40Clinical attentionCancer
2021
Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study.
Hruska CB, Geske JR, Conners AL, Whaley DH, Rhodes DJ, O'Connor MK, Carter RE, Scott CG, Vachon CM. Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study. American Journal Of Roentgenology 2021, 216: 1193-1204. PMID: 32755210, PMCID: PMC8640999, DOI: 10.2214/ajr.20.23854.Peer-Reviewed Original ResearchConceptsBackground parenchymal uptakeMolecular breast imagingPostmenopausal womenBreast cancer riskAbsolute riskBreast cancerCohort studyDiscriminatory accuracyDense breastsRisk factorsParenchymal uptakeCancer riskRisk scoreFuture breast cancer diagnosisGreater breast cancer riskBreast cancer risk factorsCox proportional hazards modelGail risk scoreBreast cancer eventsIndependent risk factorSubset of womenCancer risk factorsCase-control studyProportional hazards modelBreast cancer diagnosisComparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome
Samadder N, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze K, Golafshar M, Uson P, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez E, Lizaola-Mayo B, Lehrer M, Thorpe C, Yu N, Esplin E, Nussbaum R, Sharp R, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce A, Bekaii-Saab T, Sekulic A, Stewart A. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncology 2021, 7: 230-237. PMID: 33126242, PMCID: PMC7600058, DOI: 10.1001/jamaoncol.2020.6252.Peer-Reviewed Original ResearchConceptsPrevalence of pathogenic germline variantsFamily variant testingPathogenic germline variantsSolid tumor cancersHigh-penetrance cancer susceptibility genesFamily history of cancerMayo Clinic Cancer CenterRisk-reducing interventionsUniversal genetic testingMultigene panel testingHigh-penetrance variantsHistory of cancerClinic Cancer CenterUniversal testing approachGermline variantsGuideline-directed approachYounger age of diagnosisTumor cancersCancer susceptibility genesClinically actionable findingsTargeted testingCancer screeningAge of diagnosisGermline testingVariant testing
News
News
Get In Touch
Contacts
Locations
E.S. Harkness Memorial Hall
Academic Office
367 Cedar Street
New Haven, CT 06510